Aitken M, Taylor JA. Prevalence of clinical sinusitis in young children followed up by primary care pediatricians. Arch. Pediatr. Adolesc. Med., 1998, 152(3): 244-248.
Пронина Ю.В., Вахрушев С.Г., Буренков Г.И., Зырянов М.М. Распространенность сочетанной патологии полости носа и носоглотки у детей. Рос.ринология, 2003, 3: 56.
Fokkens WJ, Lund VJ, Mullol J, Bachert C, Gevaert P, Georgalas C et al. European Position Paper on rhinosinusitis and nasal polyps 2012. Rhinology, 2012, 50(23): 1-298.
Blin P, Blazejewski S, Lignot S, Lassalle R, Bernard MA, Jayles D et al. Effectiveness of antibiotics for acute sinusitis in real-life medical practice. Br. J. Clin. Pharmacol., 2010, 70(3): 418-428.
Гущин И.С., Ильина Н.И., Польнер С.А. Аллергический ринит: методическое пособие. М., 2002. 68.
Stjarne P, Blomgren K, Caye-Thomasen P, Salo S, Soderstrom T. The efficacy and safety of once-daily mometasone furoate nasal spray in nasal polyposis: a randomized, double-blind, placebo-controlled study. Acta Otolaryngol., 2006, 126(6): 606-612.
Meltzer EO, Bachert C, Staudinger H. Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. Allergy Clin. Immunol, 2005, 116(6): 1289-1295.
Meltzer EO, Bachert C, Staudinger H. Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. Allergy Clin. Immunol, 2005, 116(6): 1289-1295.
Davies RJ, Nelson HS. Once-daily mometasone furoate nasal spray: efficacy and safety of a new intranasal glucocorticoid for allergic rhinitis. Clin. Ther, 1997,19(1) : 27-38.
Minshall E, Ghaffar O, Cameron L, O'Brien F, Quinn H, Rowe-Jones J et al. Assessment by nasal biopsy of long-term of mometasone furoate aqueous nasal spray (Nasonex) in the treatment of perennial rhinitis. Otolaryngol. Head Neck Surg., 1998, 118(5): 648-654.
Benninger MS, Ahmad N, Marple BF. The safety of intranasal steroids. Otolaryngol. Head Neck Surg, 2003, 129: 739-750.
Temoly P. Safety of intranasal corticosteroids in acute rhinosinusitis. Am. J. Otolaryngol., 2008, 29(6): 403-413.
Klossek JM. Efficacy and safety of mometasone furoate nasal spray in the treatment of sinusitis or acute rhinosinusitis. Rev. Laryngol. Otol. Rhinol, 2007, 128(3): 187-192.
Klossek JM. Efficacy and safety of mometasone furoate nasal spray in the treatment of sinusitis or acute rhinosinusitis. Rev. Laryngol. Otol. Rhinol, 2007, 128(3): 187-192.
Ratner PH, Meltzer EO, Teper A. Mometasone furoate nasal spray is safe and effective for 1-year treatment of children with perennial allergic rhinitis. Int. J. Pediatr. Otorhinolaryngol, 2009, 73(5): 651-657.
Skoner TA, Skoner TP, Rachelefsky GS, Meltzer EO, Chervinsky P, Morris RM et al. Detection of growth suppression in children during treatment with intranasal beclomethasone dipropionate. Pediatrics, 2000, 105: 23.
Zitt M, Kosoglou T, Hubbell J. Mometasone furoate nasal spray: a review of safety and systemic effects. DrugSaf., 2007, 30(4): 317-326.
Mosges R, Bachert C, Rudack C, Hauswald B, Klimek L, Spaeth J et al. Efficacy and safety of Mometasone Furoate nasal spray in the treatment of chronic rhinosinusitis. Adv. Ther., 2011, 28(3): 238-249.
Berlucchi M, Pedruzzi B. Intranasal Mometasone Furoate for treatment of allergic rhinitis. Therapeutics, 2010, 2: 761-769.
Cervin A, Andersson M. Intranasal steroids and septum perforation - an overlooked complication? A description of the course of events and a discussion of the causes. Rhinology, 1998, 36: 128-132.
Курбачева О.М., Ильина Н.И. Лечение аллергического ринита: когда, как и зачем? Рос. аллергол. журнал, 2006, 2: 71-80.
Meltzer EO, Tripathy I, Maspero JF, Wu W, Philpot E. Safety and tolerability of fluticasone furoate nasal spray once daily in paediatric patients aged 6-11 years with allergic rhinitis: subanalysis of three randomized, double-blind, placebo-controlled, multicentre studies. Clin. DrugInvestig, 2009, 29(2): 79-86.
Tesrosiers M, Hussain A, Frenkiel S, Kilty S, Marsan J, Witterick I et al. Intranasal corticosteroid use is associated with lower rates of bacterial recovery in chronic rhinosinusitis. Otolaryngol. Head Neck Surg., 2007, 136(4): 605-609.